Genetron Holdings Stock Working Capital
Genetron Holdings fundamentals help investors to digest information that contributes to Genetron Holdings' financial success or failures. It also enables traders to predict the movement of Genetron Stock. The fundamental analysis module provides a way to measure Genetron Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genetron Holdings stock.
Genetron |
Genetron Holdings Company Working Capital Analysis
Genetron Holdings' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Genetron Holdings Working Capital | 319.08 M |
Most of Genetron Holdings' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genetron Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionAccording to the company's disclosures, Genetron Holdings has a Working Capital of 319.08 M. This is 25.04% lower than that of the Biotechnology sector and 31.11% lower than that of the Health Care industry. The working capital for all United States stocks is 78.41% higher than that of the company.
Genetron Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genetron Holdings' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genetron Holdings could also be used in its relative valuation, which is a method of valuing Genetron Holdings by comparing valuation metrics of similar companies.Genetron Holdings is currently under evaluation in working capital category among its peers.
Genetron Fundamentals
| Return On Equity | -0.92 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (1.24) % | |||
| Operating Margin | (0.87) % | |||
| Current Valuation | 102.87 M | |||
| Shares Outstanding | 31.62 M | |||
| Shares Owned By Insiders | 6.82 % | |||
| Shares Owned By Institutions | 12.51 % | |||
| Number Of Shares Shorted | 20.78 K | |||
| Price To Book | 1.68 X | |||
| Price To Sales | 0.20 X | |||
| Revenue | 650.71 M | |||
| Gross Profit | 337.97 M | |||
| EBITDA | (546.24 M) | |||
| Net Income | (810.63 M) | |||
| Cash And Equivalents | 472.68 M | |||
| Cash Per Share | 5.10 X | |||
| Total Debt | 158.57 M | |||
| Debt To Equity | 0.18 % | |||
| Current Ratio | 2.83 X | |||
| Book Value Per Share | 17.90 X | |||
| Cash Flow From Operations | (460.2 M) | |||
| Short Ratio | 0.29 X | |||
| Earnings Per Share | (3.62) X | |||
| Target Price | 1.34 | |||
| Number Of Employees | 993 | |||
| Beta | 0.5 | |||
| Market Capitalization | 127.29 M | |||
| Total Asset | 975.33 M | |||
| Retained Earnings | (6.25 B) | |||
| Working Capital | 319.08 M | |||
| Z Score | -9.27 | |||
| Net Asset | 975.33 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Genetron Stock
If you are still planning to invest in Genetron Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetron Holdings' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |